Lirong Zhang Selected Research

Antioxidants

10/2022	Ferrostatin-1 alleviates tissue and cell damage in diabetic retinopathy by improving the antioxidant capacity of the Xc--GPX4 system.
1/2020	Chitoheptaose Promotes Heart Rehabilitation in a Rat Myocarditis Model by Improving Antioxidant, Anti-Inflammatory, and Antiapoptotic Properties.
1/2020	Activation of NRF2 ameliorates oxidative stress and cystogenesis in autosomal dominant polycystic kidney disease.
1/2019	Chitosan Oligosaccharides Show Protective Effects in Coronary Heart Disease by Improving Antioxidant Capacity via the Increase in Intestinal Probiotics.
1/2018	Citrus aurantium Naringenin Prevents Osteosarcoma Progression and Recurrence in the Patients Who Underwent Osteosarcoma Surgery by Improving Antioxidant Capability.
1/2017	Alginate Oligosaccharide DP5 Exhibits Antitumor Effects in Osteosarcoma Patients following Surgery.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lirong Zhang Research Topics

Disease

52	Neoplasms (Cancer) 04/2024 - 08/2009
9	Inflammation (Inflammations) 01/2023 - 01/2019
8	Neoplasm Metastasis (Metastasis) 01/2023 - 09/2014
8	Breast Neoplasms (Breast Cancer) 09/2019 - 06/2008
6	Autosomal Dominant Polycystic Kidney (ADPKD) 01/2022 - 01/2019
6	Hypoxia (Hypoxemia) 12/2020 - 09/2014
5	Infections 03/2023 - 06/2014
5	Pancreatic Neoplasms (Pancreatic Cancer) 10/2022 - 04/2018
4	Esophageal Squamous Cell Carcinoma 04/2024 - 03/2016
4	Drug-Related Side Effects and Adverse Reactions 08/2023 - 12/2016
4	Urinary Bladder Neoplasms (Bladder Cancer) 01/2023 - 10/2019
4	Cysts 01/2023 - 01/2019
4	Hepatocellular Carcinoma (Hepatoma) 01/2022 - 12/2013
4	Type 2 Diabetes Mellitus (MODY) 11/2021 - 01/2019
3	Pneumonia (Pneumonitis) 03/2023 - 01/2020
3	Reperfusion Injury 01/2023 - 11/2022
3	Diabetic Retinopathy (Retinopathy, Diabetic) 01/2023 - 11/2021
3	Carcinogenesis 01/2023 - 06/2008
3	Obesity 07/2022 - 01/2020
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2020 - 08/2015
3	Hypersensitivity (Allergy) 01/2019 - 01/2016
2	Fibrosis (Cirrhosis) 12/2023 - 02/2023
2	Acute Kidney Injury (Acute Renal Failure) 06/2023 - 11/2022
2	Ischemia 01/2023 - 01/2023
2	Wounds and Injuries (Trauma) 11/2022 - 10/2020
2	Liver Neoplasms (Liver Cancer) 07/2022 - 01/2019
2	Esophageal Neoplasms (Esophageal Cancer) 01/2022 - 07/2021
2	Multiple Myeloma 01/2022 - 11/2018
2	Lymphatic Metastasis 01/2022 - 01/2014
2	Body Weight (Weight, Body) 01/2021 - 12/2019
2	Lung Neoplasms (Lung Cancer) 12/2020 - 01/2020
2	Myocardial Infarction 12/2020 - 01/2019
2	Infarction (Infarctions) 01/2020 - 01/2019
2	Papillary Thyroid Cancer 12/2019 - 03/2019
2	Colonic Neoplasms (Colon Cancer) 01/2018 - 07/2017
2	Osteosarcoma (Osteogenic Sarcoma) 01/2018 - 01/2017
2	Long QT Syndrome 09/2014 - 01/2011
2	Cataract (Cataracts) 01/2013 - 05/2005

Drug/Important Bio-Agent (IBA)

12	Proteins (Proteins, Gene)FDA Link 01/2023 - 06/2008
10	Biomarkers (Surrogate Marker)IBA 12/2023 - 01/2016
7	CytokinesIBA 01/2023 - 06/2014
6	AntioxidantsIBA 10/2022 - 01/2017
5	ProdrugsIBA 04/2024 - 01/2020
5	Messenger RNA (mRNA)IBA 01/2024 - 01/2014
5	Peptides (Polypeptides)IBA 12/2023 - 01/2019
4	EnzymesIBA 01/2023 - 11/2011
4	Therapeutic UsesIBA 10/2022 - 01/2017
4	OligosaccharidesIBA 01/2020 - 01/2017
4	ChitosanIBA 01/2020 - 01/2019
3	Immune Checkpoint InhibitorsIBA 12/2023 - 10/2019
3	CarbonIBA 06/2023 - 01/2017
3	Contrast MediaIBA 06/2023 - 12/2016
3	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 05/2005
3	CateninsIBA 12/2022 - 11/2018
3	Hyaluronic Acid (Hyaluronan)IBA 11/2021 - 01/2019
3	Small Interfering RNA (siRNA)IBA 07/2021 - 09/2014
3	Long Noncoding RNAIBA 01/2021 - 11/2018
3	GadoliniumIBA 04/2020 - 01/2017
3	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2020 - 01/2020
3	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2020 - 07/2018
3	HMGB1 Protein (HMG1)IBA 02/2019 - 04/2018
3	MicroRNAs (MicroRNA)IBA 01/2019 - 01/2018
3	ResveratrolIBA 11/2018 - 01/2015
2	PlatinumIBA 04/2024 - 12/2023
2	astaxanthine (astaxanthin)IBA 12/2023 - 10/2020
2	HLA Antigens (Human Leukocyte Antigens)IBA 08/2023 - 12/2016
2	CollagenIBA 02/2023 - 01/2023
2	dimethylethylsilylimidazoleIBA 01/2023 - 01/2020
2	PotassiumIBA 01/2023 - 01/2023
2	ChromatinIBA 01/2023 - 11/2022
2	Retinaldehyde (Retinal)IBA 01/2023 - 01/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 10/2022 - 12/2020
2	ChemokinesIBA 10/2022 - 01/2016
2	LigandsIBA 10/2022 - 01/2016
2	TeaIBA 07/2022 - 12/2018
2	Positive Transcriptional Elongation Factor BIBA 01/2022 - 01/2019
2	Antineoplastic Agents (Antineoplastics)IBA 01/2022 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 01/2019
2	Amino Acids FDA Link 01/2022 - 01/2021
2	InflammasomesIBA 09/2021 - 12/2020
2	Cancer VaccinesIBA 05/2021 - 01/2020
2	VaccinesIBA 01/2020 - 01/2020
2	Interleukin-12 (IL 12)IBA 01/2020 - 06/2014
2	Phosphotransferases (Kinase)IBA 01/2020 - 01/2020
2	PolyphenolsIBA 12/2019 - 12/2018
2	AntibodiesIBA 10/2019 - 01/2016
2	AngiopoietinsIBA 09/2019 - 01/2019
2	TIE-2 Receptor (Receptor, TIE 2)IBA 09/2019 - 01/2019
2	Toll-Like Receptor 2IBA 02/2019 - 01/2019
2	RNA-Directed DNA Polymerase (Reverse Transcriptase)IBA 02/2019 - 07/2017
2	AllergensIBA 01/2019 - 01/2016
2	Oxygen (Dioxygen)IBA 01/2019 - 01/2016
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2013 - 11/2011

Therapy/Procedure

24	Therapeutics 04/2024 - 01/2016
11	Drug Therapy (Chemotherapy) 12/2023 - 01/2018
6	Radiotherapy 01/2022 - 01/2017
3	Precision Medicine 01/2021 - 01/2017
3	Oral Administration 01/2021 - 01/2017
2	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2024 - 03/2015
2	Immunotherapy 12/2023 - 10/2019